Title
Category
Credits
Event date
Cost
- 1.00 AAFP Prescribed
$0.00
Despite the successes demonstrated by Accountable Care Organizations (ACOs) over the last decade, health disparities remain a critical and ever-growing challenge. ACOs have the potential to advance health equity, but without intentionality and guardrails in place, they are also in a position to worsen existing health disparities. For ACOs to truly succeed in improving patient health outcomes for all, it's imperative that health equity is kept at the forefront of value-based care efforts. Learning Objective:At the end of this session, learners should be able to:
- S.U.D
$0.00
This program will help overcome barriers to California providers wishing to begin offering Medication for Opioid Use Disorder (MOUD) and provide effective education to all interested family physicians. Patient-facing healthcare providers will learn to recognize OUD stigma, communicate more effectively, and be more confident in choosing MOUD.
- 1.00 AAFP Prescribed
- 1.00 AMA PRA Category 1 Credit™
- 1.00 AOA Category 2-A
$0.00
Recently, six California payors signed a memorandum of understanding committing to work together on a shared set of goals designed to improve the provision of primary care in California over the next three years. These goals include increased transparency, practice transformation and person-centered care.
- Miscellaneous
- 0.75 AAFP Prescribed
$0.00
Everyone talks about the barriers caused by the EHR, about hours spent entering data, about time after clinic which could be spent with family. Using what’s she’s learned in her practice, Karen Muchowski will share tips on changes YOU can make as an individual to improve your efficiency, so you can eliminate the Work After Clinic (WAC).Learning Objective:At the end of this session, learners should be able to:
- S.U.D
- 1.00 AAFP Prescribed
$0.00
Join Family Physician Rebecca Trotsky-Sirr and Sergeant Brian Gunsolley for a discussion of how patients are obtaining Fentanyl and other synthetic opioids and how physicians can help their patients recognize and understand the dangers of non-prescribed medication as well as encourage the use of reversal agents. In addition, resources will be provided to encourage more use of Medication Assisted Treatment.Learning Objectives:At the end of this session, learners should be able to:
$0.00
CAFP and attorney Scott Kessenick presented a webinar to members to highlight new laws of note in California, including issues and actions for physicians to consider when providing a "Nurse Practitioner Independent Practice Provider Attestation;" notice requirements of the Open Payments Database under Assembly Bill 1278 (2022); and rules that are reverting with the end of the public health emergency.Target Audience:This activity is designed for family medicine physicians, and other primary care team members.
- 3.00 AAFP Prescribed
$0.00
The 2023 All Member Advocacy Meeting (AMAM) focused on health equity and provided tools and information to help develop family physicians trained and dedicated to being effective advocates for their patients and specialty. This course contains the recordings from the following sessions: Keynote - Born to be an Advocate, Evaluating Policy with an Equity Lens, and Other Advocacy Avenues: Running for Office, Serving on Advisory Committees.Learning Objective:At the end of this session, learners should be able to:
- S.U.D
- 0.50 AAFP Prescribed
- 0.50 AMA PRA Category 1 Credit™
- 0.50 AOA Category 2-A
$0.00
This activity is part of CAFP's California Residency Program Collaborative around improving education, outreach and treatment for patients with substance use disorder disease, including stimulants and opioids, with a focus on medication assisted treatment options.Learning Objective:At the end of this session, learners should be able to:
- S.U.D
- 0.75 AAFP Prescribed
- 0.75 AMA PRA Category 1 Credit™
- 0.75 AOA Category 2-A
$0.00
This activity is part of CAFP's California Residency Program Collaborative around improving education, outreach and treatment for patients with substance use disorder disease, including stimulants and opioids, with a focus on medication assisted treatment options. Learning Objectives:At the end of this session, learners should be able to:
- S.U.D
- 1.00 AAFP Prescribed
- 1.00 AMA PRA Category 1 Credit™
- 1.00 AOA Category 2-A
$0.00
This activity is part of CAFP's California Residency Program Collaborative around improving education, outreach and treatment for patients with substance use disorder disease, including stimulants and opioids, with a focus on medication assisted treatment options.Learning Objective:At the end of this session, learners should be able to: